Mohamed Magda F, Sroor Farid M, Ibrahim Nada S, Salem Ghada S, El-Sayed Hadeer H, Mahmoud Marwa M, Wagdy Menna-Allah M, Ahmed Amina M, Mahmoud Aya-Allah T, Ibrahim Somia S, Ismail Mariam M, Eldin Sanaa Mohy, Saleh Fatma M, Hassaneen Hamdi M, Abdelhamid Ismail A
Department of Chemistry (Biochemistry Branch), Faculty of Science, Cairo University, Giza, Egypt.
Department of Chemistry, Faculty of Science and Arts, Khulais, University of Jeddah, Jeddah, Saudi Arabia.
Invest New Drugs. 2021 Feb;39(1):98-110. doi: 10.1007/s10637-020-00987-2. Epub 2020 Aug 28.
Two novel chemotherapeutic chalcones were synthesized and their structures were confirmed by different spectral tools. Theoretical studies such as molecular modeling were done to detect the mechanism of action of these compounds. In vitro cytotoxicity showed a strong effect against all tested cell lines (MCF7, A459, HepG2, and HCT116), and low toxic effect against normal human melanocytes (HFB4). The lung carcinoma cell line was chosen for further molecular studies. Real-time PCR demonstrated that the two compounds upregulated gene expression of (BAX, p53, casp-3, casp-8, casp-9) genes and decreased the expression of anti-apoptotic genes bcl2, CDK4, and MMP1. Flow-cytometry indicated that cell cycle arrest of A459 was induced at the G2/M phase and the apoptotic percentage increased significantly compared to the control sample. Cytochrome c oxidase and VEGF enzyme activity were detected by ELISA assay. SEM tool was used to follow the morphological changes that occurred on the cell surface, cell granulation, and average roughness of the cell surface. The change in the number and morphology of mitochondria, cell shrinkage, increase in the number of cytoplasmic organelles, membrane blebbing, chromatin condensation, and apoptotic bodies were observed using TEM. The obtained data suggested that new chalcones exerted their pathways on lung carcinoma through induction of two pathways of apoptosis. Graphical abstract Novel chalcones were prepared and confirmed by different spectral tools. Docking simulations were done to detect the mechanism of action. In vitro cytotoxicity indicated a strong effect against different cancer cell lines and low toxic effects against normal human melanocytes (HFB4). The lung carcinoma cell line was chosen for further molecular studies that include Real-time PCR, Flow-cytometry, Cytochrome c oxidase, and ELISA assay. SEM and TEM tool were used to follow the morphological changes occurred on the cell surface.
合成了两种新型化疗查耳酮,并通过不同的光谱工具确认了它们的结构。进行了诸如分子建模等理论研究以检测这些化合物的作用机制。体外细胞毒性显示对所有测试细胞系(MCF7、A459、HepG2和HCT116)有强烈作用,而对正常人黑素细胞(HFB4)毒性较低。选择肺癌细胞系进行进一步的分子研究。实时PCR表明这两种化合物上调了(BAX、p53、casp-3、casp-8、casp-9)基因的表达,并降低了抗凋亡基因bcl2、CDK4和MMP1的表达。流式细胞术表明A459细胞周期在G2/M期被阻滞,与对照样品相比凋亡百分比显著增加。通过ELISA测定法检测细胞色素c氧化酶和VEGF酶活性。使用扫描电子显微镜(SEM)工具观察细胞表面发生的形态变化、细胞颗粒化和细胞表面平均粗糙度。使用透射电子显微镜(TEM)观察线粒体数量和形态的变化、细胞收缩、细胞质细胞器数量增加、膜泡形成、染色质浓缩和凋亡小体。获得的数据表明新型查耳酮通过诱导两条凋亡途径对肺癌发挥作用。图形摘要 制备了新型查耳酮并通过不同的光谱工具进行了确认。进行对接模拟以检测作用机制。体外细胞毒性表明对不同癌细胞系有强烈作用,而对正常人黑素细胞(HFB4)毒性较低。选择肺癌细胞系进行进一步的分子研究,包括实时PCR、流式细胞术、细胞色素c氧化酶和ELISA测定法。使用SEM和TEM工具观察细胞表面发生的形态变化。